...Tokyo:4593) 5/26/15 $59.6 $391.0 $416.5 7% Collegium Pharmaceutical Inc. (NASDAQ:COLL) 5/7/15 $80.0 $246.9 $367.1 49% Verseon Corp....

...European companies have been flocking to NASDAQ to raise cash from U.S. investors. But California's Verseon Corp....
...shares at 202p in an IPO on the London Stock Exchange's AIM. The price valued Verseon...
...$165 million) in 2014. Verseon has gained 9.5p to 211.5p since it started trading. Following Verseon's...

...price values Verseon at L302.5 million ($457.9 million). Cenkos Securities plc was advisor and broker. Verseon...
...development. Verseon is developing direct thrombin inhibitors as oral anticoagulants for cardiovascular conditions. In 2009, Verseon...
...Kita held a combined 72.4% stake in the company. Additional investors included Godrej Industries and Verseon's...